Dec. 19 (Bloomberg) -- Bloomberg's Eric Chemi take a look at the two most popular erectile dysfunction medications on the market, Viagra and Cialis. Pfizer, the maker of Viagra, eliminated 20% of its sales workforce on December 18.
Winner of a video, I have been researching "getting a stiffy" for a while now, and I think this has helped. Have you heard people talk about - Aidenzey Hard Framework - (do a google search ) ? Ive heard some awesome things about it and my co-worker got great success with it.
BOTH of these ED prescription medications have now been linked with certain cancers (most notably, melanoma)... along with Levitra, Staxyn, Stendra, and PAH Medications Revatio/ Adcirca.
AVOID AT ALL COSTS, guys. These public service announcements are not just negative hype for the sake of **negative hype**... nor are they merely another mass panic-pitch on the part of shameless attorneys, meant to spur controversy/ new cases galore. These products will MESS YOU UP.
I am so tired of seeing these ads for hardon pills. The ones with women should not be on. The ones with all the couples are stupid. Why can't you just tell about the pills without having 4 or 5 couples and the stupid bathtubs at the end sitting next to a spring or lake is insane. all these ads are not needed.
This is just superb, been searching for "conquering ED" for a while now, and I think this has helped. You ever tried - Aidenzey Hard Framework - ( search on google ) ? Ive heard some decent things about it and my work buddy got cool results with it.
The class of drugs that Levitra, Viagra, Stendra, and Cialis belong to are called PDE5 inhibitors. They work by relaxing tight blood vessels, allowing more blood to surge into the penis and cause an erection, says Gregory Bales, M.D., an associate professor of urology at the University of Chicago.
The little pills do the trick for more than two-thirds of men with Viagra protects the heart (ED). They also work for guys who simply need them for a short time to get their “confidence back,” says Michael Eisenberg, M.D., director of male reproductive medicine and surgery at Stanford University.